Cairn Therapeutics transforms the treatment of cancer by overcoming the current limitations of the current therapies. While tremendous advances have been made in the fight against cancer over the last two decades, it has not been enough. Too many people, young and old, still lose their battle with cancer, and those who survive often experiencedebilitating side effects from the drugs used to treat them. Our passion to make a positive difference in this regard is embodied in CT-262, the first in a new class of DNA binding agents that has the potential to revolutionize the use of chemotherapy.

Cairn Therapeutics

Similar companies